Your browser is no longer supported. Please, upgrade your browser.
MNTA Momenta Pharmaceuticals, Inc. daily Stock Chart
MNTA [NASD]
Momenta Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.80 Insider Own0.40% Shs Outstand117.13M Perf Week6.29%
Market Cap3.98B Forward P/E- EPS next Y-1.82 Insider Trans-64.24% Shs Float116.49M Perf Month4.86%
Income-284.80M PEG- EPS next Q-0.39 Inst Own- Short Float5.32% Perf Quarter15.29%
Sales28.60M P/S139.07 EPS this Y-29.10% Inst Trans-0.85% Short Ratio5.33 Perf Half Y75.90%
Book/sh3.66 P/B9.37 EPS next Y-11.70% ROA-55.20% Target Price44.63 Perf Year215.26%
Cash/sh3.99 P/C8.59 EPS next 5Y- ROE-77.40% 52W Range9.51 - 39.88 Perf YTD73.85%
Dividend- P/FCF- EPS past 5Y-8.90% ROI-65.60% 52W High-13.99% Beta1.52
Dividend %- Quick Ratio5.90 Sales past 5Y-14.50% Gross Margin- 52W Low260.67% ATR2.13
Employees118 Current Ratio5.90 Sales Q/Q117.10% Oper. Margin- RSI (14)50.50 Volatility4.55% 6.94%
OptionableYes Debt/Eq0.00 EPS Q/Q26.00% Profit Margin- Rel Volume0.65 Prev Close33.63
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume1.16M Price34.30
Recom2.30 SMA20-2.33% SMA503.55% SMA20036.61% Volume753,037 Change1.99%
Mar-12-20Initiated Goldman Neutral $29
Jan-15-20Upgrade JP Morgan Neutral → Overweight $30
Nov-12-19Initiated SunTrust Buy $29
Nov-06-19Initiated Wells Fargo Outperform
Sep-25-19Initiated H.C. Wainwright Buy $24
Jan-04-19Downgrade JP Morgan Overweight → Neutral
Nov-05-18Initiated Piper Jaffray Overweight
Feb-22-18Upgrade Stifel Hold → Buy $18 → $21
Oct-05-17Downgrade Stifel Buy → Hold $22 → $15
Sep-28-17Initiated Goldman Neutral $18
May-22-17Downgrade Barclays Overweight → Equal Weight $20 → $17
Feb-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-31-17Reiterated Barclays Overweight $19 → $20
Nov-22-16Initiated Aegis Capital Hold
Oct-11-16Upgrade Barclays Equal Weight → Overweight $13 → $19
Sep-07-16Downgrade Maxim Group Hold → Sell $6
Jun-06-16Initiated Goldman Neutral $14
Jan-08-16Upgrade Maxim Group Sell → Hold
Nov-13-15Initiated JP Morgan Overweight
Aug-06-15Downgrade Goldman Buy → Neutral
Jul-06-20 07:32AM  
Jun-29-20 10:45AM  
Jun-26-20 12:00PM  
07:30AM  
Jun-19-20 10:02AM  
Jun-17-20 12:12PM  
09:53AM  
Jun-16-20 10:05AM  
09:58AM  
08:13AM  
Jun-15-20 02:08PM  
07:05AM  
Jun-06-20 11:31AM  
Jun-03-20 08:08AM  
03:03AM  
Jun-02-20 07:43PM  
May-29-20 06:25PM  
May-13-20 11:54AM  
May-12-20 07:55AM  
May-09-20 10:34AM  
May-08-20 12:31AM  
May-07-20 07:00AM  
Apr-30-20 12:33PM  
Apr-23-20 08:00AM  
Apr-13-20 11:00AM  
Apr-07-20 02:10PM  
Apr-02-20 07:30AM  
Mar-30-20 11:12PM  
Mar-27-20 11:30AM  
Mar-17-20 02:04PM  
Feb-28-20 08:54AM  
Feb-27-20 03:08PM  
Feb-26-20 08:45AM  
07:00AM  
Feb-19-20 12:31PM  
08:00AM  
Feb-12-20 10:55AM  
08:00AM  
Feb-07-20 11:25AM  
Jan-23-20 10:14AM  
Jan-21-20 06:21PM  
Jan-15-20 08:22AM  
06:08AM  
Jan-13-20 07:10AM  
Jan-03-20 08:05AM  
Dec-24-19 08:00AM  
Dec-13-19 08:33AM  
08:00AM  
Dec-12-19 08:00AM  
Dec-11-19 07:21AM  
Dec-10-19 08:05PM  
04:04PM  
Nov-18-19 02:44PM  
Nov-10-19 09:02AM  
Nov-07-19 08:00AM  
Nov-06-19 08:00AM  
Oct-31-19 09:45AM  
07:00AM  
Oct-27-19 02:01PM  
Oct-24-19 10:32AM  
Oct-17-19 08:00AM  
Sep-19-19 08:00AM  
Sep-16-19 01:32PM  
Sep-01-19 09:30AM  
Aug-08-19 03:45PM  
07:17AM  
Aug-05-19 04:35PM  
10:59AM  
Aug-02-19 08:25AM  
07:00AM  
Aug-01-19 04:05PM  
Jul-30-19 07:00AM  
Jul-26-19 10:30AM  
Jul-19-19 08:00AM  
Jun-19-19 08:00AM  
Jun-17-19 03:54PM  
Jun-04-19 07:30AM  
Jun-01-19 09:31AM  
May-28-19 03:39PM  
May-09-19 08:00AM  
May-07-19 03:41PM  
May-03-19 08:26PM  
May-02-19 03:16PM  
10:05AM  
09:01AM  
07:00AM  
Apr-25-19 10:33AM  
Apr-18-19 08:00AM  
Mar-29-19 07:35AM  
Mar-28-19 07:00AM  
Mar-27-19 06:13PM  
Mar-24-19 09:30AM  
Mar-21-19 08:43AM  
Mar-12-19 11:38AM  
Mar-01-19 06:38AM  
Feb-28-19 02:01PM  
Feb-25-19 10:28AM  
Feb-22-19 10:05AM  
06:47AM  
06:30AM  
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases in the United States. Its novel therapeutic programs include M281, a fully-human anti-neonatal Fc receptor (FcRn), aglycosylated immunoglobulin G (IgG1), and monoclonal antibody to reduce circulating IgG antibodies by blocking endogenous IgG recycling via FcRn; M230, a recombinant trivalent human IgG1 Fc multimer containing three IgG Fc regions joined to maximize activity; and M254, a hyper-sialylated immunoglobulin to treat various inflammatory diseases, including idiopathic thrombocytopenic purpura and chronic inflammatory demyelinating polyneuropathy. The company's biosimilar programs comprise M923, a biosimilar of HUMIRA for the treatment of patients with rheumatoid arthritis, crohn's disease, ulcerative colitis, and psoriasis; and M710, a biosimilar of EYLEA for the treatment of neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema (DME), and diabetic retinopathy in patients with DME. Its complex generics programs include Enoxaparin sodium injection, a generic version of LOVENOX that is indicated for the prevention and treatment of deep vein thrombosis, as well as supports the treatment of acute coronary syndromes; GLATOPA, a generic version of once-daily COPAXONE for the treatment of patients with relapsing forms of multiple sclerosis; and GLATOPA, a generic version of three-times-weekly COPAXONE. The company has collaboration and license agreements with Sandoz AG, Mylan Ireland Limited, and CSL Behring Recombinant Facility AG. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BELTRAMELLO JO ANNChief HR and Inf. OfficerJul 08Sale34.354,094140,62956,975Jul 09 05:54 PM
Arroyo SantiagoSVP, Chief Medical OfficerJun 30Sale35.106,812239,10145,538Jul 01 09:15 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJun 30Sale35.106,812239,10161,069Jul 01 09:16 PM
Carvajal AlejandraChief Legal OfficerJun 30Sale35.106,811239,06627,445Jul 01 09:14 PM
KWON YOUNGChief Financial & Bus. OfficerJun 30Sale35.116,810239,099157,936Jul 01 09:15 PM
Cieplinska AgnieszkaChief Accounting Officer (PAO)Jun 30Sale35.1194733,2497,574Jul 01 09:15 PM
Manning Anthony M.Chief Scientific OfficerJun 30Sale35.106,811239,06629,191Jul 01 09:14 PM
FIER IANChief Mfg and Program OfficerJun 30Sale35.106,811239,06624,123Jul 01 09:14 PM
WHEELER CRAIG APresident & CEOJun 30Sale33.3237,5751,251,99954,664Jul 01 09:13 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJun 18Sale34.904,122143,85852,881Jun 22 04:08 PM
KWON YOUNGChief Financial & Bus. OfficerJun 12Sale30.156,756203,693149,746Jun 15 05:21 PM
Cieplinska AgnieszkaChief Accounting Officer (PAO)Jun 12Sale30.1594028,3415,371Jun 15 05:24 PM
Manning Anthony M.Chief Scientific OfficerJun 12Sale30.156,756203,69321,002Jun 15 05:25 PM
Carvajal AlejandraChief Legal OfficerJun 12Sale30.156,756203,69319,256Jun 15 05:25 PM
Arroyo SantiagoSVP, Chief Medical OfficerJun 12Sale30.166,756203,76137,350Jun 15 05:26 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJun 12Sale30.156,756203,69357,003Jun 15 05:27 PM
FIER IANChief Mfg and Program OfficerJun 12Sale30.156,756203,69315,934Jun 15 05:29 PM
WHEELER CRAIG APresident & CEOJun 12Sale30.5637,5751,148,29254,664Jun 15 05:32 PM
DOWNEY BRUCEDirectorJun 05Option Exercise12.3415,000185,10047,590Jun 09 05:51 PM
FIER IANChief Mfg and Program OfficerMay 20Option Exercise18.851,42526,8619,508May 21 05:06 PM
FIER IANChief Mfg and Program OfficerMay 20Sale31.061,81856,4677,690May 21 05:06 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 15Sale30.7367320,68148,759May 19 04:34 PM
WHEELER CRAIG APresident & CEOMay 13Sale31.232,77886,75715,313May 14 06:04 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 11Option Exercise12.766,25079,75055,682May 12 04:47 PM
Manning Anthony M.Chief Scientific OfficerMay 11Sale33.7541413,97312,758May 12 04:49 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 11Sale32.466,250202,87549,432May 12 04:47 PM
WHEELER CRAIG APresident & CEOMay 08Sale32.942,60285,71011,919May 11 04:24 PM
FIER IANChief Mfg and Program OfficerMay 08Sale33.3031910,6238,083May 11 04:23 PM
Manning Anthony M.Chief Scientific OfficerMay 08Sale33.3033611,18913,172May 11 04:22 PM
KWON YOUNGChief Financial & Bus. OfficerMay 08Sale33.3062920,946141,502May 11 04:20 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 08Sale33.3060120,01349,432May 11 04:20 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 07Option Exercise18.852,69150,72551,379May 11 04:20 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMay 07Sale33.012,69188,83050,033May 11 04:20 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerApr 24Sale31.221,21938,05748,688Apr 28 05:24 PM
FIER IANChief Mfg and Program OfficerApr 22Sale31.111,31440,8797,690Apr 24 04:13 PM
Manning Anthony M.Chief Scientific OfficerApr 21Sale30.551,88657,61712,758Apr 22 04:08 PM
KWON YOUNGChief Financial & Bus. OfficerApr 20Sale28.971,61446,758140,722Apr 21 04:20 PM
Manning Anthony M.Chief Scientific OfficerApr 20Sale28.961,61446,74114,644Apr 21 04:19 PM
FIER IANChief Mfg and Program OfficerApr 20Sale28.971,12432,5629,004Apr 21 04:21 PM
Arroyo SantiagoSVP, Chief Medical OfficerApr 20Sale28.961,61446,74129,106Apr 21 04:22 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerApr 20Sale28.971,12432,56249,907Apr 21 04:21 PM
Carvajal AlejandraChief Legal OfficerApr 20Sale28.971,12432,56211,012Apr 21 04:21 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerApr 15Sale27.001,92251,89448,593Apr 17 04:15 PM
Cieplinska AgnieszkaChief Accounting Officer (PAO)Apr 14Sale29.5792127,2343,161Apr 14 06:07 PM
WHEELER CRAIG APresident & CEOMar 10Sale28.753479,97654,664Mar 10 04:43 PM
WHEELER CRAIG APresident & CEOMar 06Sale28.5137,2281,061,37055,011Mar 09 05:27 PM
KWON YOUNGChief Financial & Bus. OfficerMar 06Sale28.967,356213,030138,836Mar 09 05:17 PM
Manning Anthony M.Chief Scientific OfficerMar 06Sale29.007,310211,99012,758Mar 09 05:15 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMar 06Sale29.007,310211,99050,515Mar 09 05:16 PM
FIER IANChief Mfg and Program OfficerMar 06Sale29.007,310211,9907,690Mar 09 05:14 PM
Carvajal AlejandraChief Legal OfficerMar 06Sale29.005,302153,7589,698Mar 09 05:14 PM
Arroyo SantiagoSVP, Chief Medical OfficerMar 06Sale28.977,356213,10327,220Mar 09 05:12 PM
FIER IANChief Mfg and Program OfficerFeb 20Option Exercise13.853,78852,45315,931Feb 24 07:26 PM
FIER IANChief Mfg and Program OfficerFeb 20Sale33.3715,931531,5710Feb 24 07:26 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 19Sale33.4559119,76942,825Feb 20 05:06 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 18Sale32.8913,750452,23843,416Feb 20 05:06 PM
Manning Anthony M.Chief Scientific OfficerFeb 18Sale32.5616,459535,9055,068Feb 20 05:06 PM
WHEELER CRAIG APresident & CEOFeb 14Option Exercise13.2621,894290,31439,372Feb 19 06:42 PM
Carvajal AlejandraChief Legal OfficerFeb 14Sale31.546,892217,3740Feb 19 06:43 PM
WHEELER CRAIG APresident & CEOFeb 14Sale32.0021,894700,60817,478Feb 19 06:42 PM
FIER IANChief Mfg and Program OfficerFeb 13Sale30.036,689200,87112,143Feb 14 06:53 PM
Carvajal AlejandraChief Legal OfficerFeb 13Sale30.033,10893,3336,892Feb 14 06:52 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 13Sale30.039,016270,750130,103Feb 14 06:54 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 13Sale30.0313,356401,10857,166Feb 14 06:55 PM
WHEELER CRAIG APresident & CEOFeb 13Sale30.822,77885,61817,478Feb 14 06:53 PM
Arroyo SantiagoSVP, Chief Medical OfficerFeb 13Sale30.037,689230,90119,576Feb 14 06:55 PM
Manning Anthony M.Chief Scientific OfficerFeb 13Sale30.038,541256,48622,316Feb 14 06:54 PM
WHEELER CRAIG APresident & CEOFeb 12Option Exercise13.264,58160,74418,665Feb 14 06:53 PM
Manning Anthony M.Chief Scientific OfficerFeb 12Sale31.6378924,95621,527Feb 14 06:54 PM
WHEELER CRAIG APresident & CEOFeb 12Sale32.014,581146,63814,084Feb 14 06:53 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 11Option Exercise12.7625,000319,00070,913Feb 12 05:29 PM
WHEELER CRAIG APresident & CEOFeb 11Option Exercise13.2635,302468,10551,159Feb 12 06:00 PM
FIER IANChief Mfg and Program OfficerFeb 11Sale32.2335011,2811,332Feb 12 05:28 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 11Sale32.2335011,281111,619Feb 12 05:27 PM
Manning Anthony M.Chief Scientific OfficerFeb 11Sale32.231123,6105,857Feb 12 05:28 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 11Sale31.5125,528804,26743,022Feb 12 05:29 PM
WHEELER CRAIG APresident & CEOFeb 11Sale32.0937,0751,189,73514,084Feb 12 06:00 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Option Exercise10.832,36325,59145,913Feb 12 05:29 PM
FIER IANChief Mfg and Program OfficerFeb 10Sale31.502136,7101,682Feb 11 07:04 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 10Sale31.5040812,852111,969Feb 11 07:02 PM
WHEELER CRAIG APresident & CEOFeb 10Sale31.432,60181,74915,857Feb 11 07:03 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Sale31.5060519,05843,550Feb 11 07:03 PM
Manning Anthony M.Chief Scientific OfficerFeb 10Sale31.502247,0565,969Feb 11 07:01 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Sale31.002,36373,25368,550Feb 12 05:29 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 07Option Exercise18.852,69150,72545,501Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 07Option Exercise13.264,89064,84117,567Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 07Sale32.044,890156,67612,677Feb 11 07:03 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 07Sale31.062,69183,58244,155Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 05Option Exercise13.2612,229162,15724,906Feb 07 05:19 PM
WHEELER CRAIG APresident & CEOFeb 05Sale30.2112,229369,43812,677Feb 07 05:19 PM
WHEELER CRAIG APresident & CEOFeb 04Option Exercise13.2615,505205,59628,182Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 04Sale30.0415,505465,77012,677Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 03Option Exercise13.265,59974,24318,276Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 03Sale30.025,599168,08212,677Feb 05 05:19 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 24Sale28.191,21934,36442,810Jan 27 05:49 PM
FIER IANChief Mfg and Program OfficerJan 22Sale28.981,57745,7011,182Jan 24 04:41 PM
Carvajal AlejandraChief Legal OfficerJan 22Sale28.981,57745,7010Jan 24 04:41 PM
Manning Anthony M.Chief Scientific OfficerJan 22Sale29.012,26565,7105,443Jan 24 04:40 PM
KWON YOUNGChief Financial & Bus. OfficerJan 21Sale30.081,23537,149110,968Jan 22 05:13 PM
Arroyo SantiagoSVP, Chief Medical OfficerJan 21Sale30.081,23537,1492,265Jan 22 05:15 PM